Antisympathetic and hemodynamic property of a dual L/N-type Ca 2+ channel blocker cilnidipine in rats

By Takahara A.   Koganei H.   Takeda T.   Iwata S.  

European Journal of Pharmacology, Vol. 434, Iss. 1, 2002-01 ,pp. : 43-47

Elsevier

Access to resources Recommend Favorite

The L/N-type Calcium Channel Blocker, Cilnidipine, Reduces Heart Rate and Albuminuria in Patients with Type 2 Diabetes

By Tanaka M  

The Journal of International Medical Research, Vol. 38, Iss. 2, 2010-03 ,pp. : 602-610

Field House Publishing

Access to resources Recommend Favorite

Switching to an L/N-type Calcium Channel Blocker Shows Renoprotective Effects in Patients with Chronic Kidney Disease: the Kyoto Cilnidipine Study

By Hatta T   Takeda K   Shiotsu Y   Sugishita C   Adachi T   Kimura T   Sonomura K   Kusaba T   Kishimioto N   Narumiya H   Tanda S   Tamagaki K   Yamada K   Kameyama H   Kido H   Harada S   Bito Y   Moriguchi J   Morimoto S   Okigaki M   Itoh H   Mori Y   Nakata T   Maki K   Sasaki S   Sawada K   Matsubara H  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1417-1428

Field House Publishing

Access to resources Recommend Favorite

Prophylactic effects of an N- and L-type Ca²⁺ antagonist, cilnidipine, against cardiac hypertrophy and dysfunction in stroke-prone, spontaneously hypertensive rats

By Takemori Kumiko   Ishida Hiroyuki   Dote Kensaku   Yamamoto Kazuo   Ito Hiroyuki  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 8-9, 2005-08 ,pp. : 785-790

NRC Research Press

Access to resources Recommend Favorite

L-type Ca²⁺ channel blocker attenuates impairment induced by acidosis in hippocampal neurons

By Zeng Xianghui   Zhang Yanli   Qing Chen   Zhang Hongbin  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 11, 2013-11 ,pp. : 889-892

Govi-Verlag

Access to resources Recommend Favorite